Chirality and its implications for the pharmaceutical industry
作者： Hans-Ulrich Blaser
DOI: 10.1007/S12210-012-0220-2
关键词:
摘要: … , the implications for synthesis and application of chiral drugs are discussed. In a first part, … ; here the time factor is usually not so important but a high performance process is necessary. …
springer.com
sci-hub.se 参考文章(9)
Chirality in drug research Methods and Principles in Medicinal Chemistry. ,vol. 33, ,(2006) , 10.1002/3527609431
Joseph Gal, Chiral Drugs from a Historical Point of View Methods and Principles in Medicinal Chemistry. pp. 1- 26 ,(2006) , 10.1002/9783527609437.CH1
Hans-Ulrich Blaser, Industrial Asymmetric Hydrogenation Applications of Transition Metal Catalysis in Drug Discovery and Development. pp. 315- 342 ,(2012) , 10.1002/9781118309872.CH8
Andreas Taugerbeck, Kazuaki Tarumi, Detlef Pauluth, Joachim Krause, Michael Heckmeier, Peer Kirsch, Chiral compounds ii ,(2001)
Carl A. Busacca, Daniel R. Fandrick, Jinhua J. Song, Chris H. Senanayake, The Growing Impact of Catalysis in the Pharmaceutical Industry Advanced Synthesis & Catalysis. ,vol. 353, pp. 1825- 1864 ,(2011) , 10.1002/ADSC.201100488
Wilson H. De Camp, The FDA perspective on the development of stereoisomers. Chirality. ,vol. 1, pp. 2- 6 ,(1989) , 10.1002/CHIR.530010103
John S. Carey, David Laffan, Colin Thomson, Mike T. Williams, Analysis of the reactions used for the preparation of drug candidate molecules. Organic and Biomolecular Chemistry. ,vol. 4, pp. 2337- 2347 ,(2006) , 10.1039/B602413K
Trevor Laird, Applications of Transition Metal Catalysis in Drug Discovery and Development Organic Process Research & Development. ,vol. 16, pp. 1874- 1874 ,(2012) , 10.1021/OP300277X
G. W. Muller, Thalidomide : From tragedy to new drug discovery Chemtech. ,vol. 27, pp. 21- 25 ,(1997)